Glenmark Pharmaceuticals
GLENMARK.NS
$25.76
Share price
-4.48%
Change (1 day)
35.86%
Change (1 year)
Categories
Earnings for Glenmark Pharmaceuticals (GLENMARK.NS)
Earnings in 2024 (TTM): A$0.40 Billion
According to Glenmark Pharmaceuticals 's latest financial reports the company's current earnings are A$1.53 Billion. , an increase over its 2023 earnings that were of -A$98.95 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Glenmark Pharmaceuticals from 2012 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | A$0.42 B | -529.64% |
| 2023 | -A$98.95 Million | -129.25% |
| 2022 | A$0.33 B | -13.93% |
| 2021 | A$0.39 B | 4.71% |
| 2020 | A$0.37 B | 18.76% |
| 2019 | A$0.31 B | -15.93% |
| 2018 | A$0.37 B | 36.53% |
| 2017 | A$0.27 B | -31.84% |
| 2016 | A$0.40 B | 66.82% |
| 2015 | A$0.24 B | 8.58% |
| 2014 | A$0.22 B | -18.39% |
| 2013 | A$0.27 B | 3.66% |
| 2012 | A$0.26 B |